Tracking intellectual and motor development in babies at high risk for cerebral palsy
Official title: The ELEVATE Program for Prediction, Early Detection & Intervention in Cerebral Palsy
Run by University College Cork · NCT06857539 · Data updated 2026-11-12
This project will follow babies at higher risk for cerebral palsy to see if early thinking and movement signs predict later intellectual and motor outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Days to 4 Months |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | University College Cork Academic / other |
| Locations | 4 sites (Cork and 3 other locations) |
| Status | Recruiting |
| Started | March 21, 2025 |
| Main results expected | July 31, 2030 |
| Study ends | July 31, 2030 |
| Registry record updated | May 13, 2026 |
| Trial ID | NCT06857539 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Infants who are deemed high risk for cerebral palsy—such as those born ≤32 weeks or ≤1500 g, encephalopathic infants, or those with abnormal neuroimaging or persistent abnormal exams—whose legal guardians can give consent, plus a recruited control group.
✕Probably not a fit
Infants who die before discharge or whose parents do not consent cannot participate and will not benefit, and babies without high-risk features or with already established outcomes are less likely to gain from enrollment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational follow-up enrolls infants considered at high risk for cerebral palsy alongside a control group and tracks their motor and cognitive development over time. High-risk enrollment includes infants born ≤32 weeks or ≤1500 g, infants with encephalopathy, or those with abnormal neurological exams or neuroimaging findings. Care teams including neonatologists and physiotherapists perform standardized clinical exams, and brain scans are used when concerns arise, with progress documented in outpatient clinics and community early intervention referrals made as needed. Data will be analyzed to identify early signs that predict later intellectual and motor outcomes.
Why it matters
Potential benefit: If successful, clinicians could identify high-risk babies who need early therapies sooner, potentially improving long-term learning and movement outcomes.
How similar studies have gone: Previous longitudinal follow-up and neonatal imaging studies have shown some predictive value for later cerebral palsy and developmental delays but prediction remains imperfect, so this study builds on existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (High Risk Group) : * Legal guardians must be able and willing to give written informed consent and to comply with the requirements of this study protocol. * All infants considered high risk for a diagnosis of cerebral palsy and neuro-developmental impairment will be eligible, specifically including: * All preterm infants born ≤32 weeks Post Menstrual Age or ≤1500 gm birth weight * All encephalopathic infants * Neurological risk factors (e.g., cerebral birth defect, injury/malformation on neuroimaging, persistently abnormal neurological exam) (Control Group) -A control arm will also be recruited. Exclusion Criteria: * Death prior to discharge from the neonatal unit (High-Risk Infants only) * No parental consent (High-Risk and Control Infants)
Where it's running
-
Cork University Maternity Hospital
Cork, Ireland Recruiting -
INFANT Centre, University College Cork
Cork, Ireland Recruiting -
The Rotunda Hospital
Dublin, Ireland Recruiting -
Coombe Women and Infant's Hospital
Dublin, Ireland Not yet recruiting
Study contacts
- Principal investigator: Deirdre M Murray — INFANT Research Centre, University College Cork, Cork, Ireland
- Study coordinator: Deirdre Murray Principal Investigator
- Email: d.murray@ucc.ie
- Phone: +353 021 420 5082
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Household, wellbeing, and quality-of-life impacts of very preterm birth and necrotising enterocolitis
This project will collect information to see if pausing or continuing milk feeds around blood transfusions relates to babies' quality of life and the financial and emotional impact on families of very preterm infants, especially those with NEC.
-
Giving surfactant to premature infants using a thin catheter at birth
This study is testing if giving a special lung treatment to very premature babies right after birth using a thin tube can help them breathe better and need less breathing support in their first few days of life.
-
Dorsal Root Electrical Stimulation to Help Spasticity in Children with Cerebral Palsy
This study tests whether adding dorsal root electrical stimulation during SDR surgery can lessen spasticity in children with cerebral palsy.
-
Combining whole body vibration and serial casting for children with cerebral palsy
This study is testing if combining whole body vibration with special casts and exercises can help children with cerebral palsy move their ankles better and improve their overall mobility.
-
Targeted fortification of donor breast milk for preterm infants
This study is testing if customizing the nutrients in donor breast milk helps preterm infants grow better than using regular methods.
-
Examining heart and lung health in extremely premature infants
This study looks at the heart and lung health of extremely premature babies to see if they have problems that could affect their future health and development.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.